STOCK TITAN

Inspire Medical Systems, Inc. to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Inspire Medical Systems, a leader in medical technology for obstructive sleep apnea, has announced its upcoming presentation at the virtual Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 3:50 p.m. Eastern Time. The event will be accessible via a live webcast, which can be found here. A replay will be available for two weeks afterward on Inspire's Investor website. The company offers Inspire therapy, the only FDA-approved neurostimulation technology for effectively treating moderate to severe obstructive sleep apnea.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, June 01, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the virtual Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020.

Inspire is scheduled to present at 3:50 p.m. Eastern Time. The presentation will be accessible via a live webcast at: https://kvgo.com/GSHC/Inspire-Medical-Systems-june-2020

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com
646-597-6989


FAQ

When will Inspire Medical Systems present at the Goldman Sachs Global Healthcare Conference?

Inspire Medical Systems is scheduled to present on June 11, 2020.

What time is Inspire's presentation at the conference?

Inspire's presentation is set for 3:50 p.m. Eastern Time.

How can I access the live webcast of Inspire's presentation?

The live webcast can be accessed at this link.

Will there be a replay available for Inspire's presentation?

Yes, a replay will be available for two weeks after the presentation on Inspire's Investor website.

What is Inspire's focus in the medical technology field?

Inspire Medical Systems focuses on innovative solutions for patients with obstructive sleep apnea.

What is Inspire therapy?

Inspire therapy is the only FDA-approved neurostimulation technology for treating moderate to severe obstructive sleep apnea.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

6.16B
29.82M
1.96%
107.82%
4.03%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY